Source: Fertility and Sterility. Conference titles: Annual Meeting of the American Society (ASRM). Unidade: FMRP
Subjects: DISPOSITIVOS ANTICONCEPCIONAIS, SÍNDROME DO OVÁRIO POLICÍSTICO, SISTEMA CARDIOVASCULAR
ABNT
VIEIRA, C. S. et al. Addition of low dose of metformin to the oral contraceptive has no great advantage in terms of cardiovascular risk markers in women with polycystic ovary syndrome regardless insulin resistance. Fertility and Sterility. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 28 nov. 2025. , 2010APA
Vieira, C. S., Fernandes, J. B. F., Soares, G. M., Martins, W. de P., Sá, M. F. S. de, & Ferriani, R. A. (2010). Addition of low dose of metformin to the oral contraceptive has no great advantage in terms of cardiovascular risk markers in women with polycystic ovary syndrome regardless insulin resistance. Fertility and Sterility. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.NLM
Vieira CS, Fernandes JBF, Soares GM, Martins W de P, Sá MFS de, Ferriani RA. Addition of low dose of metformin to the oral contraceptive has no great advantage in terms of cardiovascular risk markers in women with polycystic ovary syndrome regardless insulin resistance. Fertility and Sterility. 2010 ; 94( 4 suppl): S63-S64.[citado 2025 nov. 28 ]Vancouver
Vieira CS, Fernandes JBF, Soares GM, Martins W de P, Sá MFS de, Ferriani RA. Addition of low dose of metformin to the oral contraceptive has no great advantage in terms of cardiovascular risk markers in women with polycystic ovary syndrome regardless insulin resistance. Fertility and Sterility. 2010 ; 94( 4 suppl): S63-S64.[citado 2025 nov. 28 ]